6BERENDSEN M,KNOL B W.Treatment compliance[J].Tijdschr Diergeneeskd,2002,127(18):548-551.
7ROTER D L,HALL J A,MERISCA R,et al.Effectiveness of interventions to improve patient compliance:a meta-analysis[J].Med Care,1998,36(8):1138-1140.
8KYNGAS H A,KROOL T,DUFFY M.Compliance in adolescents with chronic diseases:A review[J].J Adolesc Health,2000,26(6):379-388.
9ROBERT J.Patients' beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness[J].J Psychosom Res,1999,47(6):555-567.
10Bemuau J, Rueff B, Benhamou JP. Fuminant and subfulmant liver failure: Definition and causes. Sem Liv Dis, 1986,6:97-106.
7Ikeda T. Drug -induced liver injury[J]. Nippon Yakurigaku Zasshi, 2006, 127(2): 454.
8长婷婷,韩亚萍.重型药物性肝炎患者的护理策略[J].护理研究,2010,17(32):101.
9Yazdani Brojeni P, Matok I, Garcia Bournissen F, et al. A systematic review of the fetal safety of interferon alpha [ J ]. Reprod Toxicol, 2012,33 (3) :265-268.
10Capuron L, Pagnoni G, Drake DF, et al. Dopaminergic mechanisms of reduced basal ganglia responses to hedonic reward during interferon alfa administration [ J ]. Arch Gen Psychiatry, 2012,69 (10) : 1044-1053.
